NEW YORK, September 10, 2015 /PRNewswire/ --

ACI Association has initiated research coverage on The Estee Lauder Companies Inc. (NYSE: EL). Select highlights from the internally released reports are being made available to the general public (included below), with access to the entirety of the research available to new members.

Today, membership is open to readers on a complementary basis at the following URL: http://www.aciassociation.com/?c=EL

Highlights from our EL Report include: 


        
        - Fourth Quarter Results - On August 17, 2015, The Estee Lauder Companies Inc.
          reported financial results for its fourth quarter and fiscal year ended June 30, 2015.
          The Company generated net sales of $2.5 billion, reflecting a decrease of 7% from $2.7
          billion in Q2 2014. Sales from America amounted to $1.1 billion, while, sales from
          Europe, the Middle East & Africa and Asia/Pacific stood at $982.4 million and $454.3
          million, respectively. Further, net earnings attributable to The Estee Lauder
          Companies Inc. reduced to $153.8 million or diluted earnings of $0.40 per share, from
          $257.7 million or diluted earnings of $0.66 per share in the previous year quarter.



        
        - Fiscal 2015 Financial Highlights - In fiscal 2015, the Company reported net sales
          of $10.8 billion, a decrease of 2% from $11.0 billion in fiscal 2014. Sales from
          America were recorded at $4.5 billion (down 1% YoY). Moreover, sales from Europe, the
          Middle East & Africa and Asia/Pacific declined by 2% YoY each, amounting to $4.1
          billion and $2.2 billion, respectively. Additionally, in fiscal 2015, net earnings
          attributable to The Estee Lauder Companies Inc. amounted to $1.1 billion, compared to
          $1.2 billion, in prior year.



        
        - Product Category Results at Glance - As per the Company, in fiscal 2015, skin care
          net sales decreased by 6% YoY, amounting to $4.5 billion, primary due to lower sales
          of significant products from the Estee Lauder and Clinique brands that were launched
          in the prior-year period. Whereas, sales from Make-up products grew to $4.3 billion
          from $4.2 billion in fiscal 2014. Furthermore, Haircare net sales increased to $530.6
          million from $515.6 million in prior fiscal. Lastly, net sales from Fragrance products
          stood at $1.4 billion, reflecting a decline of 1% YoY.



        
        - Outlook for Fiscal 2016 First Quarter and Full Year - For Q1 fiscal 2016, the
          Company expects net sales to rise around 13% to 14% in constant currency. Diluted net
          earnings per share, including the negative impact of foreign currency translation and
          acquisitions, are projected to be between $0.66 and $0.69. In addition, the
          acquisitions the Company made beginning in the second quarter of fiscal 2015 are
          forecast to contribute approximately 90 basis points to the Company's overall sales
          growth in its Q1 fiscal 2016. Further, in fiscal 2016, the Company anticipates net
          sales to increase in a range of 8% to 10% in constant currency while diluted net
          earnings per share, including the negative impact of foreign currency translation and
          acquisitions, are projected to be approximately $3.10 to $3.17.

To find out how this influences our rating on The Estee Lauder Companies Inc. read the full report in its entirety here: http://www.aciassociation.com/?c=EL

About ACI Association: 

Active Charter Investors Association ("ACI Association") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ACI Association has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

ACI Association has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:  

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA(R) charter holder (the "CFA(R)"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the CFA(R) have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the CFA(R) (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY 

ACI Association, the Author, the Reviewer and the CFA(R) (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ACI Association nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.aciassociation.com.

RESTRICTIONS 

ACI Association is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia. Do not send email to robottrap (at) aciassociation.com.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE www.aciassociation.com